OKYO Pharma annual depreciation and amortization
2020
2021
2022
2023
2024
2025
2026
OKYO Pharma Depreciation & Amortization Growth & History (OKYO)
OKYO Pharma's depreciation and amortization was $1,820 for fiscal 2026.
View full OKYO Pharma company overviewOKYO Pharma annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $1,820 | −$743 | −28.99% |
| 2025 | 2025-03-31 | $2,563 | −$1,303 | −33.70% |
| 2024 | 2024-03-31 | $3,866 | $69 | +1.82% |
| 2023 | 2023-03-31 | $3,797 | $1,374 | +56.71% |
| 2022 | 2022-03-31 | $2,423 | $911 | +60.25% |
| 2021 | 2021-03-31 | $1,512 | $1,300 | +613.21% |
| 2020 | 2020-03-31 | $212 | — | — |
OKYO Pharma depreciation and amortization trends
Over the last five fiscal years, OKYO Pharma's depreciation and amortization increased from $1,512 to $1,820, a change of $308.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review OKYO Pharma source filings ↗